Telitacicept
Modify Date: 2025-08-26 13:26:23
Telitacicept structure
|
Common Name | Telitacicept | ||
|---|---|---|---|---|
| CAS Number | 2136630-26-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TelitaciceptTelitacicept (RC18) is a fully human TACI-Fc fusion protein. Telitacicept is a dual B lymphocyte stimulator (BLyS)/APRIL (a proliferation-inducing ligand) inhibitor that effectively blocks proliferation of B lymphocytes. Telitacicept can be used in research of B-cell autoimmune disease[1]. |
| Name | Telitacicept |
|---|
| Description | Telitacicept (RC18) is a fully human TACI-Fc fusion protein. Telitacicept is a dual B lymphocyte stimulator (BLyS)/APRIL (a proliferation-inducing ligand) inhibitor that effectively blocks proliferation of B lymphocytes. Telitacicept can be used in research of B-cell autoimmune disease[1]. |
|---|---|
| Related Catalog | |
| Target |
(BLyS)/APRIL[1] |
| References |
| No Any Chemical & Physical Properties |